Cyclerion Therapeutics, Inc. Share Price
Equities
CYCN
US23255M2044
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -3.62% | -16.29% | -12.54% |
03-05 | Cyclerion Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Cyclerion Therapeutics, Inc. Appoints Regina Graul as President | CI |
Sales 2022 | 1.62 130.09 | Sales 2023 | - | Capitalization | 8.19M 656M |
---|---|---|---|---|---|
Net income 2022 | -44M -3.52B | Net income 2023 | -5M -400M | EV / Sales 2022 | 17,563,610 x |
Net cash position 2022 | 13.38 1.07K | Net cash position 2023 | 7.57 606.08 | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-1.49
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.53% |
1 day | -3.62% | ||
1 week | -16.29% | ||
Current month | -8.44% | ||
1 month | -4.87% | ||
3 months | +0.00% | ||
6 months | -2.33% | ||
Current year | -12.54% |
Managers | Title | Age | Since |
---|---|---|---|
Regina Graul
PSD | President | - | 12-03 |
Peter Hecht
BRD | Director/Board Member | 60 | 31/03/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Errol de Souza
CHM | Chairman | 70 | 25/04/21 |
Terry McGuire
BRD | Director/Board Member | 68 | 31/03/19 |
Peter Hecht
BRD | Director/Board Member | 60 | 31/03/19 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.93 | -3.62% | 276 |
25/04/24 | 3.04 | +9.75% | 442 |
24/04/24 | 2.77 | -9.18% | 717 |
22/04/24 | 3.05 | -12.86% | 3,541 |
19/04/24 | 3.5 | +8.76% | 3,300 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-12.54% | 7.44M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CYCN Stock